Company: LENZ
Filing Date: 2025-03-19
Form Type: 10-K
Source: 0001815776-25-000019
Chunk: 69

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-03-19
Form: 10-K
Item: Item 9B
Chunk 69
---
 the purpose of computing the percentage ownership of any other person. Except as noted by footnote, and subject to community property laws where applicable, based on the information provided to us, we believe that the persons and entities named in the table below have sole voting and investment power with respect to all shares shown as beneficially owned by them. Unless otherwise noted, the business address of each of the Company's directors and executive officers is 201 Lomas Santa Fe Drive Suite 300, Solana Beach, California 92075. The percentage of beneficial ownership of LENZ Therapeutics, Inc. is calculated based on 27,542,874 shares of Common Stock outstanding as of March 12, 2025.

154

Table of Contents

Name of Beneficial OwnersNumber of Shares%Greater than 5% StockholdersAlpha Wave Ventures II, LP(1)3,612,211 13.1 %Entities affiliated with Point72 Asset Management(2)1,882,693 6.8 %Entities affiliated with RA Capital Management(3)4,259,106 15.5 %Entities affiliated with Versant Management(4)4,612,684 16.7 %Ridgeback Capital Investments L.P.(5)1,951,875 7.1 %Executive Officers and DirectorsEvert Schimmelpennink(6)769,567 2.8 %Shawn Olsson(7)154,456 *Marc Odrich(8)160,312 *Daniel Chevallard(9)57,354 *Frederic Guerard(10)50,195 *James McCollum(11)636,924 2.3 %Zach Scheiner(12)9,750 *Shelley Thunen(13)9,750 *Jeff George(14)9,750 *Kimberlee C. Drapkin(15)18,188 *All directors and executive officers as a group (10 persons)(16)1,876,246 6.8 %

__________________

*Less than 1%

(1)Consists of (i) 2,714,002 shares of Common Stock received by Alpha Wave Ventures II, LP in the Merger as an equityholder of record of LENZ OpCo, and (ii) 898,209 shares of Common Stock purchased by Alpha Wave Ventures II, LP in the March 2024 PIPE Financing